Sex differences in dementia with Lewy bodies: Focused review of available evidence and future directions.

Shannon Y Chiu, Kathryn A Wyman-Chick, Tanis J Ferman, Ece Bayram, Samantha K Holden, Parichita Choudhury, Melissa J Armstrong
Author Information
  1. Shannon Y Chiu: Department of Neurology, University of Florida College of Medicine, Gainesville, FL, USA; Norman Fixel Institute for Neurologic Diseases, University of Florida, Gainesville, FL, USA. Electronic address: Shannon.Chiu@neurology.ufl.edu.
  2. Kathryn A Wyman-Chick: Center for Memory and Aging, Department of Neurology, HealthPartners, Saint Paul, MN, USA.
  3. Tanis J Ferman: Department of Psychiatry & Psychology, Mayo Clinic, Jacksonville, FL, USA.
  4. Ece Bayram: Department of Neurosciences, University of California San Diego, La Jolla, CA, USA.
  5. Samantha K Holden: Department of Neurology, University of Colorado School of Medicine, Aurora, CO, USA.
  6. Parichita Choudhury: Cleo Roberts Center, Banner Sun Health Research Institute, Sun City, AZ, USA.
  7. Melissa J Armstrong: Department of Neurology, University of Florida College of Medicine, Gainesville, FL, USA; Norman Fixel Institute for Neurologic Diseases, University of Florida, Gainesville, FL, USA.

Abstract

In this review, we summarize the current knowledge on sex differences in dementia with Lewy bodies (DLB) relating to epidemiology, clinical features, neuropathology, biomarkers, disease progression, and caregiving. While many studies show a higher DLB prevalence in men, this finding is inconsistent and varies by study approach. Visual hallucinations may be more common and occur earlier in women with DLB, whereas REM sleep behavior disorder may be more common and occur earlier in men. Several studies report a higher frequency of parkinsonism in men with DLB, while the frequency of fluctuations appears similar between sexes. Women tend to be older, have greater cognitive impairment at their initial visit, and are delayed in meeting DLB criteria compared to men. Women are also more likely to have Lewy body disease with co-existing AD-related pathology than so-called "pure" Lewy body disease, while men may present with either. Research is mixed regarding the impact of sex on DLB progression. Biomarker and treatment research assessing for sex differences is lacking. Women provide the majority of caregiving in DLB but how this affects the caregiving experience is uncertain. Gaining a better understanding of sex differences will be instrumental in aiding future development of sex-specific strategies in DLB for early diagnosis, care, and drug development.

Keywords

References

  1. Brain Stimul. 2020 Jul - Aug;13(4):1031-1039 [PMID: 32334074]
  2. Neurology. 2017 Jul 4;89(1):88-100 [PMID: 28592453]
  3. Neurosci Biobehav Rev. 2019 Jul;102:95-105 [PMID: 30959072]
  4. Sleep Med. 2013 Aug;14(8):754-62 [PMID: 23474058]
  5. Clin Exp Pharmacol Physiol. 2007 Jul;34(7):555-65 [PMID: 17581209]
  6. Neuropsychology. 2008 Nov;22(6):729-37 [PMID: 18999346]
  7. Psychiatr Times. 2018 Nov;35(11):14-17 [PMID: 30820070]
  8. Alzheimers Res Ther. 2020 Oct 29;12(1):137 [PMID: 33121510]
  9. Alzheimers Res Ther. 2014 Apr 25;6(2):21 [PMID: 25031635]
  10. Brain Res. 2019 Sep 15;1719:11-16 [PMID: 31128096]
  11. Dement Geriatr Cogn Disord. 2009;28(4):314-9 [PMID: 19844105]
  12. Eur J Pharmacol. 2021 Mar 15;895:173862 [PMID: 33450279]
  13. Eur J Nucl Med Mol Imaging. 2021 May;48(5):1445-1459 [PMID: 33130960]
  14. Alzheimers Dement. 2022 Apr;18(4):591-601 [PMID: 34761850]
  15. J Alzheimers Dis. 2022;86(4):1935-1946 [PMID: 35253760]
  16. Acta Neuropathol. 2015 May;129(5):729-48 [PMID: 25758940]
  17. BMJ Open. 2017 Nov 3;7(11):e017504 [PMID: 29101136]
  18. JAMA Neurol. 2013 Feb;70(2):223-8 [PMID: 23407718]
  19. Neurology. 2020 Jul 14;95(2):e155-e165 [PMID: 32561678]
  20. J Alzheimers Dis. 2021;82(4):1847-1859 [PMID: 34219734]
  21. Eur J Neurol. 2020 Jun;27(6):928-943 [PMID: 32056347]
  22. Nat Genet. 2021 Mar;53(3):294-303 [PMID: 33589841]
  23. Alzheimers Res Ther. 2015 Feb 03;7(1):5 [PMID: 25713600]
  24. Parkinsonism Relat Disord. 2020 Nov;80:184-193 [PMID: 33260030]
  25. BMJ Open. 2012 Feb 08;2:e000380 [PMID: 22318660]
  26. Psychogeriatrics. 2020 Sep;20(5):737-745 [PMID: 32743894]
  27. Int J Geriatr Psychiatry. 2016 Sep;31(9):1075-83 [PMID: 26765199]
  28. J Alzheimers Dis. 2020;77(1):165-174 [PMID: 32804137]
  29. Neurology. 2011 Aug 30;77(9):875-82 [PMID: 21849645]
  30. JAMA Neurol. 2013 Jun;70(6):727-35 [PMID: 23588557]
  31. J Clin Psychiatry. 2005 May;66(5):633-7 [PMID: 15889951]
  32. J Neurol Neurosurg Psychiatry. 2017 Feb;88(2):113-118 [PMID: 27794030]
  33. J Alzheimers Dis. 2017;57(3):787-795 [PMID: 28304294]
  34. J Alzheimers Dis. 2016 Aug 18;54(1):287-95 [PMID: 27567832]
  35. Dialogues Clin Neurosci. 2016 Dec;18(4):437-446 [PMID: 28179815]
  36. Alzheimers Res Ther. 2020 Apr 17;12(1):44 [PMID: 32303272]
  37. Psychol Med. 2014 Mar;44(4):673-83 [PMID: 23521899]
  38. Front Psychiatry. 2021 Oct 27;12:753864 [PMID: 34777057]
  39. Neurology. 2018 Sep 18;91(12):e1182-e1195 [PMID: 30143564]
  40. BJPsych Open. 2020 Jun 16;6(4):e61 [PMID: 32539875]
  41. Neurology. 2021 Feb 2;96(5):e684-e697 [PMID: 33199437]
  42. Neurology. 2010 Aug 10;75(6):494-9 [PMID: 20668263]
  43. J Alzheimers Dis. 2018;64(2):505-513 [PMID: 29889064]
  44. Alzheimers Res Ther. 2018 Sep 12;10(1):92 [PMID: 30208961]
  45. Can J Neurol Sci. 2016 Apr;43 Suppl 1:S83-95 [PMID: 27307129]
  46. Sleep. 2018 Feb 1;41(2): [PMID: 29216391]
  47. J Am Med Dir Assoc. 2016 Aug 1;17(8):706-11 [PMID: 27168051]
  48. Neurology. 1998 Aug;51(2):351-7 [PMID: 9710002]
  49. Gerontologist. 2011 Feb;51(1):76-85 [PMID: 20667944]
  50. Int Psychogeriatr. 2013 May;25(5):843-9 [PMID: 23211760]
  51. Alzheimers Res Ther. 2021 Feb 26;13(1):53 [PMID: 33637117]
  52. J Neurol Neurosurg Psychiatry. 2016 Sep;87(9):952-7 [PMID: 26701996]
  53. Mov Disord. 2016 Jul;31(7):1066-70 [PMID: 27027900]
  54. Clin Epidemiol. 2014 Jan 08;6:37-48 [PMID: 24470773]
  55. J Int Neuropsychol Soc. 2020 Feb;26(2):210-225 [PMID: 31826772]
  56. Sleep Med. 2021 May;81:180-187 [PMID: 33714847]
  57. Neurology. 2020 Jan 21;94(3):e282-e291 [PMID: 31862783]
  58. Neuroimage Clin. 2020;27:102333 [PMID: 32674011]
  59. Mov Disord. 2022 Jul;37(7):1505-1515 [PMID: 35531707]
  60. Sleep. 2016 Jan 01;39(1):121-32 [PMID: 26940460]
  61. Brain. 2019 Jan 1;143(1):31-46 [PMID: 31612904]
  62. Front Neurol. 2020 Sep 18;11:576121 [PMID: 33071952]
  63. Alzheimers Res Ther. 2021 Jan 23;13(1):31 [PMID: 33485373]
  64. Arch Gen Psychiatry. 2005 Jun;62(6):685-91 [PMID: 15939846]
  65. Brain. 2007 Mar;130(Pt 3):708-19 [PMID: 17267521]
  66. Front Neurol. 2022 Jan 31;12:805135 [PMID: 35173668]
  67. Sleep Med. 2015 Mar;16(3):414-8 [PMID: 25660814]
  68. Sleep. 2019 Jul 8;42(7): [PMID: 30946468]
  69. Neurology. 2021 Aug 24;97(8):e825-e835 [PMID: 34088871]
  70. Neurology. 2018 Dec 26;: [PMID: 30587514]
  71. JAMA Neurol. 2013 Nov;70(11):1396-402 [PMID: 24042491]
  72. Psychogeriatrics. 2021 Jan;21(1):142-143 [PMID: 33107106]
  73. Brain. 2011 May;134(Pt 5):1493-1505 [PMID: 21596773]
  74. Front Neuroendocrinol. 2018 Jul;50:18-30 [PMID: 28974386]
  75. J Clin Sleep Med. 2019 Dec 15;15(12):1789-1798 [PMID: 31855164]
  76. Alzheimers Dement. 2018 Mar;14(3):330-339 [PMID: 29100980]
  77. Alzheimers Res Ther. 2016 Jan 26;8:3 [PMID: 26812908]
  78. Alzheimers Res Ther. 2018 Feb 15;10(1):19 [PMID: 29448953]
  79. Neurology. 2012 Nov 6;79(19):1944-50 [PMID: 23035075]
  80. Clin Neuropsychol. 2006 Dec;20(4):623-36 [PMID: 16980250]
  81. Lancet Neurol. 2017 Jan;16(1):55-65 [PMID: 27979356]
  82. Neurotherapeutics. 2022 Jan;19(1):55-67 [PMID: 34859379]
  83. Alzheimers Res Ther. 2019 Oct 10;11(1):83 [PMID: 31601267]
  84. Neurol Sci. 2022 Jun;43(6):3541-3550 [PMID: 35332438]
  85. Parkinsonism Relat Disord. 2016 Oct;31:72-78 [PMID: 27475955]
  86. J Alzheimers Dis. 2021;80(1):421-432 [PMID: 33554912]
  87. J Neurol. 2010 Nov;257(11):1875-81 [PMID: 20563821]
  88. J Neurol Neurosurg Psychiatry. 2018 Nov;89(11):1167-1173 [PMID: 29853532]
  89. Int Psychogeriatr. 2018 Aug;30(8):1131-1138 [PMID: 29223171]
  90. Alzheimers Res Ther. 2022 Jan 21;14(1):14 [PMID: 35063023]
  91. JAMA Neurol. 2016 Nov 01;73(11):1334-1341 [PMID: 27654968]
  92. Gend Med. 2007 Jun;4(2):120-9 [PMID: 17707846]
  93. J Neurol Neurosurg Psychiatry. 2004 Mar;75(3):382-7 [PMID: 14966152]
  94. J Parkinsons Dis. 2019;9(3):501-515 [PMID: 31282427]
  95. Neuropsychiatr Dis Treat. 2013;9:927-35 [PMID: 23847419]
  96. JAMA Neurol. 2017 Mar 01;74(3):310-315 [PMID: 28114455]
  97. Parkinsonism Relat Disord. 2013 Jan;19(1):120-2 [PMID: 22726815]
  98. Brain Imaging Behav. 2017 Feb;11(1):205-213 [PMID: 26843008]
  99. Am J Physiol Heart Circ Physiol. 2014 Mar;306(6):H781-8 [PMID: 24414073]
  100. Alzheimers Dement. 2020 Mar;16(3):524-530 [PMID: 32043803]
  101. Alzheimers Dement. 2020 Aug;16(8):1173-1181 [PMID: 32558217]
  102. Mov Disord. 2016 Aug;31(8):1203-8 [PMID: 27296778]
  103. Alzheimer Dis Assoc Disord. 2010 Apr-Jun;24(2):177-81 [PMID: 20505434]
  104. Neurobiol Aging. 2021 Sep;105:252-261 [PMID: 34130107]
  105. J Neurol Neurosurg Psychiatry. 2021 Jul;92(7):745-750 [PMID: 33563809]
  106. PLoS One. 2020 Oct 7;15(10):e0239279 [PMID: 33027276]
  107. J Neuroimaging. 2021 May;31(3):579-587 [PMID: 33476487]
  108. J Neurol Neurosurg Psychiatry. 2008 Dec;79(12):1331-8 [PMID: 18653550]
  109. Alzheimers Dement. 2017 Mar;13(3):257-266 [PMID: 27521790]
  110. J Alzheimers Dis. 2012;29(1):125-32 [PMID: 22207004]
  111. Neurology. 2006 Dec 12;67(11):1935-41 [PMID: 17159097]
  112. Int J Geriatr Psychiatry. 2018 Jan;33(1):193-199 [PMID: 28295599]
  113. Exp Neurol. 2009 Jun;217(2):434-9 [PMID: 19289119]
  114. Brain. 2019 Mar 1;142(3):744-759 [PMID: 30789229]
  115. Neurology. 2020 Dec 15;95(24):e3257-e3268 [PMID: 32989106]

Grants

  1. RF1 NS121099/NINDS NIH HHS
  2. R01 NS121099/NINDS NIH HHS
  3. P30 AG017266/NIA NIH HHS
  4. P50 AG047266/NIA NIH HHS
  5. R21 AG072153/NIA NIH HHS
  6. U19 AG071754/NIA NIH HHS
  7. P30 AG062677/NIA NIH HHS
  8. R21 AG074368/NIA NIH HHS
  9. K23 AG073525/NIA NIH HHS
  10. K99 AG073453/NIA NIH HHS
  11. R01 AG068128/NIA NIH HHS
  12. R44 AG062072/NIA NIH HHS
  13. U01 NS100620/NINDS NIH HHS

MeSH Term

Humans
Female
Male
Lewy Body Disease
Sex Characteristics
Parkinsonian Disorders
REM Sleep Behavior Disorder
Hallucinations
Biomarkers

Chemicals

Biomarkers

Word Cloud

Created with Highcharts 10.0.0DLBLewymensexdifferencesdiseasecaregivingmayWomenbodyreviewdementiabodiesprogressionstudieshighercommonoccurearlierfrequencyfuturedevelopmentSexDementiasummarizecurrentknowledgerelatingepidemiologyclinicalfeaturesneuropathologybiomarkersmanyshowprevalencefindinginconsistentvariesstudyapproachVisualhallucinationswomenwhereasREMsleepbehaviordisorderSeveralreportparkinsonismfluctuationsappearssimilarsexestendoldergreatercognitiveimpairmentinitialvisitdelayedmeetingcriteriacomparedalsolikelyco-existingAD-relatedpathologyso-called"pure"presenteitherResearchmixedregardingimpactBiomarkertreatmentresearchassessinglackingprovidemajorityaffectsexperienceuncertainGainingbetterunderstandingwillinstrumentalaidingsex-specificstrategiesearlydiagnosiscaredrugbodies:Focusedavailableevidencedirections

Similar Articles

Cited By